Surgery Partners Price to Sales Ratio 2013-2024 | SGRY
Historical PS ratio values for Surgery Partners (SGRY) over the last 10 years. The current P/S ratio for Surgery Partners as of March 03, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Surgery Partners P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-28 | 24.08 | 1.02 | |
| 2024-09-30 | 32.24 | $23.70 | 1.36 |
| 2024-06-30 | 23.79 | $22.95 | 1.04 |
| 2024-03-31 | 29.83 | $22.15 | 1.35 |
| 2023-12-31 | 31.99 | $21.78 | 1.47 |
| 2023-09-30 | 29.25 | $23.61 | 1.24 |
| 2023-06-30 | 44.99 | $25.23 | 1.78 |
| 2023-03-31 | 34.47 | $26.91 | 1.28 |
| 2022-12-31 | 27.86 | $28.20 | 0.99 |
| 2022-09-30 | 23.40 | $28.93 | 0.81 |
| 2022-06-30 | 28.92 | $28.88 | 1.00 |
| 2022-03-31 | 55.05 | $29.80 | 1.85 |
| 2021-12-31 | 53.41 | $32.55 | 1.64 |
| 2021-09-30 | 42.34 | $35.37 | 1.20 |
| 2021-06-30 | 66.62 | $38.59 | 1.73 |
| 2021-03-31 | 44.26 | $38.42 | 1.15 |
| 2020-12-31 | 29.01 | $38.16 | 0.76 |
| 2020-09-30 | 21.90 | $37.63 | 0.58 |
| 2020-06-30 | 11.57 | $36.84 | 0.31 |
| 2020-03-31 | 6.53 | $38.39 | 0.17 |
| 2019-12-31 | 15.66 | $37.97 | 0.41 |
| 2019-09-30 | 7.39 | $37.48 | 0.20 |
| 2019-06-30 | 8.14 | $37.13 | 0.22 |
| 2019-03-31 | 11.28 | $37.00 | 0.30 |
| 2018-12-31 | 9.79 | $36.89 | 0.27 |
| 2018-09-30 | 16.50 | $36.19 | 0.46 |
| 2018-06-30 | 14.90 | $33.53 | 0.44 |
| 2018-03-31 | 17.15 | $30.42 | 0.56 |
| 2017-12-31 | 12.10 | $27.82 | 0.44 |
| 2017-09-30 | 10.35 | $24.64 | 0.42 |
| 2017-06-30 | 22.75 | $24.19 | 0.94 |
| 2017-03-31 | 19.50 | $24.22 | 0.81 |
| 2016-12-31 | 15.85 | $23.82 | 0.67 |
| 2016-09-30 | 20.24 | $24.50 | 0.83 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.198B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |